STUDYID,USUBJID,SUBJID,SITEID,SITEGR1,ARM,TRT01P,TRT01PN,TRT01A,TRT01AN,TRTSDT,TRTEDT,TRTDURD,AVGDD,CUMDOSE,AGE,AGEGR1,AGEGR1N,AGEU,RACE,RACEN,SEX,ETHNIC,SAFFL,ITTFL,EFFFL,COMP8FL,COMP16FL,COMP24FL,DISCONFL,DSRAEFL,DTHFL,BMIBL,BMIBLGR1,HEIGHTBL,WEIGHTBL,EDUCLVL,DISONSDT,DURDIS,DURDSGR1,VISIT1DT,RFSTDTC,RFENDTC,VISNUMEN,RFENDT,DCDECOD,EOSSTT,DCSREAS,MMSETOT
CDISCPILOT01,01-701-1015,1015,701,701,Placebo,Placebo,0.0,Placebo,0.0,2014-01-02,2014-07-02,182.0,0.0,0.0,63.0,<65,1.0,YEARS,WHITE,1.0,F,HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.1,25-<30,147.3,54.4,16.0,2010-04-30,43.9,>=12,2013-12-26,2014-01-02,2014-07-02,12.0,2014-07-02,COMPLETED,COMPLETED,,23.0
CDISCPILOT01,01-701-1023,1023,701,701,Placebo,Placebo,0.0,Placebo,0.0,2012-08-05,2012-09-01,28.0,0.0,0.0,64.0,<65,1.0,YEARS,WHITE,1.0,M,HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,30.4,>=30,162.6,80.3,14.0,2006-03-11,76.4,>=12,2012-07-22,2012-08-05,2012-09-02,5.0,2012-09-02,ADVERSE EVENT,DISCONTINUED,Adverse Event,23.0
CDISCPILOT01,01-701-1028,1028,701,701,Xanomeline High Dose,Xanomeline High Dose,81.0,Xanomeline High Dose,81.0,2013-07-19,2014-01-14,180.0,77.7,13986.0,71.0,65-80,2.0,YEARS,WHITE,1.0,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,31.4,>=30,177.8,99.3,16.0,2009-12-16,42.8,>=12,2013-07-11,2013-07-19,2014-01-14,12.0,2014-01-14,COMPLETED,COMPLETED,,23.0
CDISCPILOT01,01-701-1033,1033,701,701,Xanomeline Low Dose,Xanomeline Low Dose,54.0,Xanomeline Low Dose,54.0,2014-03-18,2014-03-31,14.0,54.0,756.0,74.0,65-80,2.0,YEARS,WHITE,1.0,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,28.8,25-<30,175.3,88.5,12.0,2009-08-02,55.3,>=12,2014-03-10,2014-03-18,2014-04-14,5.0,2014-04-14,STUDY TERMINATED BY SPONSOR,DISCONTINUED,Sponsor Decision,23.0
CDISCPILOT01,01-701-1034,1034,701,701,Xanomeline High Dose,Xanomeline High Dose,81.0,Xanomeline High Dose,81.0,2014-07-01,2014-12-30,183.0,76.9,14067.0,77.0,65-80,2.0,YEARS,WHITE,1.0,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,26.1,25-<30,154.9,62.6,9.0,2011-09-29,32.9,>=12,2014-06-24,2014-07-01,2014-12-30,12.0,2014-12-30,COMPLETED,COMPLETED,,21.0
CDISCPILOT01,01-701-1047,1047,701,701,Placebo,Placebo,0.0,Placebo,0.0,2013-02-12,2013-03-09,26.0,0.0,0.0,85.0,>80,3.0,YEARS,WHITE,1.0,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,30.4,>=30,148.6,67.1,8.0,2009-07-26,42.0,>=12,2013-01-22,2013-02-12,2013-03-29,6.0,2013-03-29,ADVERSE EVENT,DISCONTINUED,Adverse Event,23.0
CDISCPILOT01,01-701-1097,1097,701,701,Xanomeline Low Dose,Xanomeline Low Dose,54.0,Xanomeline Low Dose,54.0,2014-01-01,2014-07-09,190.0,54.0,10260.0,68.0,65-80,2.0,YEARS,WHITE,1.0,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,27.3,25-<30,168.9,78.0,18.0,2005-09-22,99.1,>=12,2013-12-23,2014-01-01,2014-07-09,12.0,2014-07-09,COMPLETED,COMPLETED,,10.0
CDISCPILOT01,01-701-1111,1111,701,701,Xanomeline Low Dose,Xanomeline Low Dose,54.0,Xanomeline Low Dose,54.0,2012-09-07,2012-09-16,10.0,54.0,540.0,81.0,>80,3.0,YEARS,WHITE,1.0,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,23.9,<25,158.2,59.9,22.0,2009-04-04,40.7,>=12,2012-08-25,2012-09-07,2012-09-17,4.0,2012-09-17,ADVERSE EVENT,DISCONTINUED,Adverse Event,23.0
CDISCPILOT01,01-701-1115,1115,701,701,Xanomeline Low Dose,Xanomeline Low Dose,54.0,Xanomeline Low Dose,54.0,2012-11-30,2013-01-23,55.0,54.0,2970.0,84.0,>80,3.0,YEARS,WHITE,1.0,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,23.9,<25,181.6,78.9,12.0,2004-05-28,101.9,>=12,2012-11-23,2012-11-30,2013-01-23,8.0,2013-01-23,ADVERSE EVENT,DISCONTINUED,Adverse Event,20.0
CDISCPILOT01,01-701-1118,1118,701,701,Placebo,Placebo,0.0,Placebo,0.0,2014-03-12,2014-09-09,182.0,0.0,0.0,52.0,<65,1.0,YEARS,WHITE,1.0,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,21.9,<25,180.3,71.2,14.0,2010-06-24,44.2,>=12,2014-02-27,2014-03-12,2014-09-09,12.0,2014-09-09,COMPLETED,COMPLETED,,20.0
